Literature DB >> 20122986

Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes.

Yun-Ying Wang1, Bo Jiao, Wang-Gang Guo, Hong-Lei Che, Zhi-Bin Yu.   

Abstract

Excessive thyroid hormone induces cardiac hypertrophy and promotes heart failure in patients with hyperthyroidism, but the mechanism remains elusive. Rats were orally administered with levothyroxine (100 microg/kg, T(4)) for 4 weeks to induce hyperthyroidism. The calculated stroke volume decreased and the shortening amplitude-frequency relationship in unloaded contraction of isolated cardiomyocytes was negative in T(4)-treated rats. Apoptotic rates increased and DNA laddering was also detectable in T(4)-treated rat hearts. By contrast, in primary cultured cardiomyocytes, T(3) induced dose-dependent hypertrophy but did not affect the apoptotic rate. Angiotensin II further increased the apoptotic rate of T(3)-induced hypertrophied cardiomyocytes. The apoptotic rate was dependent on the extent of cardiomyocyte hypertrophy. These results suggest that cardiac contractility is enhanced during the early stage of hyperthyroidism, but decreased during the late stage of hyperthyroidism. The hypertrophied cardiomyocytes were also susceptible to apoptotic stimulation by angiotensin II. Depressed cardiac contractility and enhanced apoptosis may lead to heart failure in hypertrophied myocardium. (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122986     DOI: 10.1016/j.mce.2010.01.031

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

1.  A Prospective Study on Cardiovascular Dysfunction in Patients with Hyperthyroidism and Its Reversal After Surgical Cure.

Authors:  Sankaran Muthukumar; Dhalapathy Sadacharan; Krishnan Ravikumar; Gajarajan Mohanapriya; Zahir Hussain; R V Suresh
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

2.  Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.

Authors:  Jun-Biao Wu; Yuan Zhou; Chun-Ling Liang; Xiao-Jun Zhang; Jie-Mei Lai; Shu-Fang Ye; Hui Ouyang; Jin Lin; Jiu-Yao Zhou
Journal:  Chin J Integr Med       Date:  2016-03-17       Impact factor: 1.978

3.  Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function.

Authors:  Nathan Y Weltman; Dajun Wang; Rebecca A Redetzke; A Martin Gerdes
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

4.  Synergistic effects between phosphorylation of phospholamban and troponin I promote relaxation at higher heart rate.

Authors:  Lin Zhang; Yuan Yu; Zhen Song; Yun-Ying Wang; Zhi-Bin Yu
Journal:  J Biomed Biotechnol       Date:  2011-08-24

Review 5.  Oxidative stress and heart failure in altered thyroid States.

Authors:  Pallavi Mishra; Luna Samanta
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 6.  Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story.

Authors:  Mohammad T Elnakish; Amany A E Ahmed; Peter J Mohler; Paul M L Janssen
Journal:  Oxid Med Cell Longev       Date:  2015-06-04       Impact factor: 6.543

Review 7.  Recurrence of differentiated thyroid carcinoma during full TSH suppression: is the tumor now thyroid hormone dependent?

Authors:  Paul J Davis; Aleck Hercbergs; Mary K Luidens; Hung-Yun Lin
Journal:  Horm Cancer       Date:  2014-10-08       Impact factor: 3.869

8.  Co-administration of Apelin and T4 protects inotropic and chronotropic changes occurring in hypothyroid rats.

Authors:  Zahra Akhondali; Mohammad Badavi; Mahin Dianat; Farzaneh Faraji
Journal:  Arq Bras Cardiol       Date:  2015-07-31       Impact factor: 2.000

9.  Determinants of thyrotoxic cardiomyopathy recovery.

Authors:  Lucia Oliveros-Ruiz; Maite Vallejo; L Fernando Diez Canseco; Manuel Cárdenas; J Antonio G Hermosillo
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

10.  Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology.

Authors:  Sibel Ertek; Arrigo F Cicero
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.